We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Gilead’s antiviral drug remdesivir showed clinical improvement in two-thirds of COVID-19 patients in a study at Los Angeles’ Cedars-Sinai Hospital. Read More
Eli Lilly’s arthritis treatment Olumiant (baricitinib) is being investigated as a potential COVID-19 treatment in one arm of a National Institutes for Allergy and Infectious Diseases adaptive trial. Read More